| Andrea Leigh Bock-kunz, MD | |
|
605 Commercial St, Atchison, KS 66002-2404 | |
| (913) 367-4451 | |
| (913) 367-7640 |
| Full Name | Andrea Leigh Bock-kunz |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 605 Commercial St, Atchison, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629075239 | NPI | - | NPPES |
| 2087299901 | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 04-28552 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Andrea Leigh Bock-kunz, MD 605 Commercial St, Atchison, KS 66002-2404 Ph: (913) 367-4451 | Andrea Leigh Bock-kunz, MD 605 Commercial St, Atchison, KS 66002-2404 Ph: (913) 367-4451 |
News Archive
Royal Philips and Netherlands-based Radboud university medical center today introduced a connected digital health prototype that enables people living with diabetes and their health care providers to make more confident care decisions while managing the complexity of diabetes self-care. In its first phase, the solution both organizations are developing will focus on patients living with diabetes type 1.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that the U.S. Food and Drug Administration has granted marketing approval of the Abbreviated New Drug Application for enoxaparin sodium for injection filed by Sandoz. Developed under a collaboration agreement between Momenta and Sandoz, this product has been designated therapeutically equivalent to the reference-listed drug, Lovenox, which is marketed by Sanofi-Aventis.
Scientists still do not know what causes epileptic seizures, but researchers from Melbourne's Howard Florey Institute are one step closer to solving this puzzle with the help of their newly developed genetically modified epileptic mouse.
Healthcare workers and people they live with are at an increased risk of contracting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Hospital healthcare workers (HCWs) worldwide have been found to have a higher number of SARS-CoV-2 infections and higher antibody seroprevalence compared to the general population.
Georgia State University faculty have received a five-year, $3 million federal grant to further develop a tool that will allow researchers around the world to participate in extensive brain imaging analysis without sharing protected patient data.
› Verified 4 days ago
James D Haug, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 605 Commercial St, Atchison, KS 66002 Phone: 913-367-4451 Fax: 913-367-7640 |